Recombinant botulinum neurotoxin serotype A1 in vivo characterization

Recombinant botulinum neurotoxin serotype A1 in vivo characterization

Abstract Clinically used botulinum neurotoxins (BoNTs) are natural products of Clostridium botulinum. A novel, recombinant BoNT type A1 (rBoNT/A1; IPN10260) has been synthesized using the native amino acid sequence expressed in Escherichia coli and has previously been characterized in vitro and ex v...

Full description

Saved in:
Bibliographic Details
Main Authors: Cindy Périer, Vincent Martin, Sylvie Cornet, Christine Favre‐Guilmard, Marie‐Noelle Rocher, Julien Bindler, Stéphanie Wagner, Emile Andriambeloson, Brian B. Rudkin, Rudy Marty, Alban Vignaud, Matthew Beard, Stephane Lezmi, Mikhail Kalinichev
Format: article
Language:EN
Published: Wiley 2021
Subjects:
botulinum
muscle
neurotoxin
recombinant
rodent
SNAP25
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/08d7dae9cde34694bf838b65c8d1a5b6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/08d7dae9cde34694bf838b65c8d1a5b6

Similar Items